Freddie Mac Announces First Quarter 2023 Financial Results

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

MCLEAN, Va., May 03, 2023 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today reported its First Quarter 2023 financial results and filed its Quarterly Report on Form 10-Q with the U.S. Securities and Exchange Commission. The company’s Form 10-Q and earnings press release, along with the First Quarter 2023 financial results supplement are available now on the Investor Relations page of the company’s website. The company will hold a call at 9 a.m. Eastern Time (ET) today, May 3, 2023, to share its results with the media. The call will be concurrently webcast, and the replay will be available on the company’s website for approximately 30 days. Freddie Mac’s mission is to make home possible for families across the nation. We promote liquidity, stability, affordability and equity in the housing market throughout all economic cycles....

Q1 2023 results in line with expectations

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

Announcement no. 8-2023 3 May 2023 North Media CEO Lasse Ingemann Brodt commented on the results for Q1 2023:“Our Q1 2023 results were in line with expectations. Once again, BoligPortal delivers record-high revenue and EBIT, driven by a large number of rental units listed, while our other three businesses, and FK Distribution in particular, reported reduced activity levels. We continued to develop our businesses in order to capitalise even more on volume and scale benefits, while staying focused on establishing the future strategic platform for the entire Group.” Financial highlights: DKKm Q1 2023 2022 Revenue 240.0 248.2 EBIT 43.8 48.2 EBIT margin 18.3% 19.4% Return on securities 103.8 -94.9 Cash flows from operating activities 57.0 37.0 Free cash flow 53.6 35.1 Performance by business area – Q1 2023 The Last...

Amerigo Announces Q1-2023 Results & Quarterly Dividend

Written by Customer Service on May 3, 2023. Posted in Dividend Reports And Estimates.

Q1-2023 net income of $9.1 million as Amerigo beats production and cash cost guidance EBITDA1of $18.5 million, cash balance grows to $43.9 million Quarterly dividend of Cdn$0.03 per share declared, representing a 7.36% yield2 VANCOUVER, British Columbia, May 03, 2023 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; OTCQX: ARREF) (“Amerigo” or the “Company”) is pleased to announce financial results for the three months ended March 31, 2023 (“Q1-2023”). Dollar amounts in this news release are in U.S. dollars unless indicated otherwise. Amerigo’s quarterly financial results included net income of $9.1 million, earnings per share (“EPS”) of $0.05 (Cdn$0.07), EBITDA1 of $18.5 million, and free cash flow to equity1 of $8.6 million. Q1-2023 financial results included $3.4 million in positive settlement adjustments to copper revenue,...

Arqit Sets First Half 2023 Conference Call for Wednesday, May 17, 2023 at 11:00 a.m. ET

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

LONDON, May 03, 2023 (GLOBE NEWSWIRE) — Arqit Quantum Inc. (“Arqit”), a global leader in quantum encryption technology, announced it will report financial results for the six months ending March 31, 2023 on Wednesday, May 17, 2023. In conjunction with this announcement, Arqit will host a conference call at 11:00 a.m. ET / 8:00 a.m. PT on May 17, 2023 with the Company’s Founder, Chairman and CEO, David Williams, and CFO, Nick Pointon. A live webcast of the call will be available on the “News & Events” page of the Company’s website at ir.arqit.uk. To access the call by phone, please go to this link (registration link) and you will be provided with dial in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. A replay of the webcast will also be...

Pacira BioSciences Reports First Quarter 2023 Financial Results

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

— EXPAREL continues to outperform elective surgery market with average daily volumes up 6 percent over prior year — — Conference call today at 8:30 a.m. ET — TAMPA, Fla., May 03, 2023 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to non-opioid pain management and regenerative health solutions, today reported financial results for the first quarter of 2023. First Quarter 2023 Financial Highlights Total revenues of $160.3 million Net product sales of $130.4 million for EXPAREL, $24.3 million for ZILRETTA, and $4.0 million for iovera° Net loss of $19.5 million, or $0.43 per share (basic and diluted) Adjusted EBITDA of $41.9 million “2023 is off to a positive start as EXPAREL continues to outperform the elective surgery market with expanding utilization across...

Conduent Reports First Quarter 2023 Financial Results

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

Key Q1 2023 Highlights Revenue and Adj. Revenue(1): $922M Pre-tax Income (Loss): $(8)M Adj. EBITDA Margin(1): 9.8% New business signings ACV(2): $125M Net ARR Activity Metric(2) (TTM): $108M FLORHAM PARK, N.J., May 03, 2023 (GLOBE NEWSWIRE) — Conduent (NASDAQ: CNDT), a global technology-led business process solutions company, today announced its first quarter 2023 financial results. Cliff Skelton, Conduent President and Chief Executive Officer stated, “Q1 Revenue and EBITDA met expectations. This performance is another proof point of our continued momentum and ability to execute with predictable outcomes. Q1 sales, as expected, were lower year-over-year for the quarter due to several large deals that are now expected to manifest in Q2 and beyond, including large contracts, specifically in the public sector. Our pipeline is strong...

Wave Life Sciences Reports First Quarter 2023 Financial Results and Provides Business Update

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

Emerging leader in RNA medicines with multi-modal discovery and development platform and first-in-class RNA editing programs Rapidly advancing toward 2023 CTA submissions and first-in-human study for WVE-006, the industry’s first RNA editing clinical candidate Planning for potentially registrational Phase 2 clinical study for WVE-N531 to assess functional dystrophin protein restoration in DMD patients, following best-in-class exon-skipping data reported in December 2022 Preparing broad suite of first- and best-in-class medicines enabled by multi-modal RNA medicine platform and proprietary genetic insights from GSK collaboration; investor event anticipated in 3Q 2023 Cash and cash equivalents of $207.6 million as of March 31, 2023, with runway expected into 2025, plus potential milestone payments from GSK collaboration in 2023 and beyond Investor...

From World-Class Asset Base, Barrick Hunts New Opportunities

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

First Quarter 2023 ResultsAll amounts expressed in US dollars TORONTO, May 03, 2023 (GLOBE NEWSWIRE) — Barrick Gold Corporation (NYSE:GOLD)(TSX:ABX) — The completion of major processing plant maintenance at Nevada Gold Mines, the conversion of the Goldstrike autoclave to a carbon-in-leach process, a much-improved performance from Turquoise Ridge and the steady ramp-up of throughput at Pueblo Viejo’s expanded plant will boost production in the second half of the year and keep Barrick on track to achieve its 2023 guidance, the company said today. Reporting on the results for the first quarter, president and chief executive Mark Bristow said production, while lower than Q4 2022, was on plan, and free cash flow1 had still increased, demonstrating the value of Barrick’s Tier One2 asset portfolio. Net earnings per share for the quarter...

Comstock Announces First Quarter 2023 Results

Written by Customer Service on May 3, 2023. Posted in Earnings Releases And Operating Results.

VIRGINIA CITY, Nev., May 03, 2023 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE: LODE) (“Comstock” and the “Company”), an innovator of technologies that enable systemic decarbonization, today announced its recent Q1 2023 operational highlights. “Over the past three months, we monetized non-strategic assets and positioned ourselves to meet or exceed our $30 million target this year. We have also advanced our fuels, metals, and mining lines of business, and GenMat, our strategic investee, announced a customer demonstration of their physics-based general artificial intelligence capabilities. We are excited that all of this drives our commercializations,” said Corrado De Gasperis, Comstock’s executive chairman and chief executive officer. Selected Strategic Highlights from the First Quarter 2023 Comstock Fuels “Our fuels team is unblocking...

Intervest Offices & Warehouses NV announces conditions for optional dividend

Written by Customer Service on May 3, 2023. Posted in Dividend Reports And Estimates.

Intervest’s supervisory board has decided to offer shareholders an optional dividend again this year. The shareholders are informed about the concrete modalities in the attached press release. Attachment PR_EN_Optional_dividend

Day: May 3, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice